Surgical drape

Information

  • Patent Grant
  • 11020199
  • Patent Number
    11,020,199
  • Date Filed
    Monday, March 14, 2016
    8 years ago
  • Date Issued
    Tuesday, June 1, 2021
    3 years ago
Abstract
Disclosed is a surgical drape configured to selectively allow or block a patient's view of the surgical field, as is desired in Caesarean section operations. Generally, the drape includes a main sheet, a substantially transparent sheet attached to the main sheet proximal the patient's head, and a substantially opaque screen attached to the patient-facing side of the substantially transparent sheet. This substantially opaque screen occludes the patient's visual access through the substantially transparent sheet but may be at least partially removed to permit the patient viewing access through the substantially transparent sheet towards the area of the surgery, without compromising the sterility of the surgical field. Desirably, the drape is provided with an adhesive strip disposed on the sheet or screen to permit reconnection to thereby again occlude the patient's view through the sheet.
Description
TECHNICAL FIELD

This patent relates to a drape for covering a patient during a surgical procedure.


BACKGROUND

Currently, a traditional Cesarean section procedure, also known as “C-section,” is most commonly performed with the patient covered by a solid surgical drape. The drape is typically constructed of a multi-layer combination of spunbond and meltblown materials, commonly referred to as SMS nonwoven fabric.


Because the mother is typically awake and alert during the C-section, it is desirable to provide a barrier or screen to occlude the mother's view of the surgical area during the procedure. Many traditional drapes are in a “T” shape, with the top portion of the “T” acting as the anesthesia screen that obscures the patient's view of the surgical area. The drape is placed over the patient to isolate a sterile field near the patient's abdomen. The anesthesia screen is propped up on vertical standards at each side of the operating table near the patient's head or on a crossbar proximal the head.


In this arrangement, the mother does not have an opportunity to see her newborn immediately after delivery. It is desirable in the first moments after birth for the mother and child to establish an immediate connection. Because traditional surgical drapes obscure the mother's view of the newborn in the first moments after delivery, the mother and child do not have an opportunity to establish this immediate connection.


To address this concern, it is known to provide surgical drapes that incorporate a coverable window and an opaque flap that can be attached and detached to alternately obscure and expose the window. It has now been realized that many such known drapes are undesirable in that they are configured in ways that might allow for contamination of the surgical field once the flap is removed, particularly if the flap is folded into the surgical field.


A new surgical drape has now been devised. Generally, the drape includes a main sheet having a first patient-facing side and a second surgeon-facing side. The main sheet includes a fenestration through which a surgical procedure may be performed. The main sheet has a head region that is located near the head of the patient during the surgical procedure, and a substantially transparent sheet attached to the main sheet proximal the head region. The substantially transparent sheet allows the patient visual access to the surgeon-facing side from behind the substantially transparent sheet. The drape also includes also a substantially opaque screen attached to the patient-facing side of the substantially transparent sheet. This substantially opaque screen occludes the patient's visual access through the substantially transparent sheet when the substantially opaque screen is attached to the substantially transparent sheet. The substantially opaque screen is at least partially removable from the substantially transparent sheet to permit the patient viewing access through the substantially transparent sheet towards the area of the surgery. In this manner, the patient may view the birth of the infant or may view the infant immediately after birth.


The drape is configured such that the substantially opaque screen may be reattached to the patient side of the substantially transparent sheet to again occlude the patient's view of the surgical site. In this manner, the surgeon, after having permitted the patient to view the surgical site through the substantially transparent sheet, may occlude the patient's view of the surgical site so that, if desired, the surgeon can continue with the procedure with the surgical area again being occluded.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective view of a surgical drape in accordance with one embodiment of the invention, shown in use positioned over a patient in a surgical bed.



FIG. 2 is a top plan view of the surgical drape shown in FIG. 1.



FIG. 3 is a front perspective view of the surgical drape shown in FIG. 1.



FIG. 4 is a rear perspective view, partially cut away, of the surgical drape and bed shown in FIG. 1, depicting the substantially opaque screen attached to the substantially transparent sheet.



FIG. 5 is a view similar to FIG. 4 but depicting top edge of the substantially opaque screen having been separated from the substantially transparent sheet.



FIG. 6 is a rear perspective view of an upper portion of the surgical drape as shown in FIGS. 1 and 4, enlarged with respect to FIGS. 1 and 4, and depicting a strip of material that connects the substantially opaque screen and the substantially transparent sheet.



FIG. 7 is a view similar to FIG. 6 but depicting the substantially opaque screen being removed from the substantially transparent sheet.



FIG. 8 is a view similar to FIG. 5 but with the substantially opaque screen reattached to the substantially transparent sheet.





Reference herein to “top” and bottom” are intended to relate the various views to one another and such reference is not intended to limit the orientation of the drape when in use.


DETAILED DESCRIPTION

Referring to FIG. 1, the surgical drape 10 includes a main sheet 11 having a center portion 12, first side portion 14, second side portion 15, and transverse portion 16. The center portion 12 has a bottom edge 17, a top edge 18, and first and second side edges 20 and 21 joining the bottom edge 17 and the top edge 18. The transverse portion 16 is attached to the center portion 12 near the top edge 18 of the center portion 12. The first side portion 14 is attached along the first side edge 20 of the center portion 12. The first side portion 14 is also attached along a lower edge 22 of the transverse portion 16. Similarly, the second side portion 15 is attached along the second side edge 21 of the center portion 12. The second side portion 15 is attached along the lower edge 22 of transverse portion 16.


The main sheet 11 and the transverse portion 16 may be constructed of any suitable material, and as shown are constructed of a multi-layer combination of spunbond and meltblown materials, commonly referred to as SMS nonwoven fabric. This combination provides a durable and absorbent flexible fluid barrier between the patient and the sterile field that are soft to the touch. The first and second side portions 14 and 15 are made of a flexible fluid impervious and non-absorbent material, such as polyethylene film.


Referring to FIGS. 2 and 3, the surgical drape 10 also includes a substantially transparent sheet 24. A bottom edge 25 of the substantially transparent sheet 24 is attached along a top edge 26 of the transverse portion 16. The length of transverse portion 16 extends the width of the surgical drape 10. The substantially transparent sheet 24 may be made of any suitable material, such as polyethylene film. Further, as seen, the substantially transparent sheet extends across the entire surgical drape transverse width of the surgical drape.


The main sheet 11 includes a fenestration 42 through which a surgery accessing a patient's body may be performed. The fenestration 42 is an opening formed in the material of main sheet 11 sized according to the particular procedure for which the surgical drape 10 is to be used. In one embodiment, fenestration 42 is sized to allow sufficient access to a patient's abdominal region to perform a C-section procedure. Fenestration 42 is covered with a flexible adhesive film 44 known in the industry as “incise film,” which may be formed from polyurethane or another suitable material to form a “full incise” fenestration. When the surgical drape 10 is laid over a patient, the flexible adhesive film 44 is first covered with a removable backing 49. Before the procedure is performed and after the surgical drape 10 is laid over the patient, the removable backing is removed from the flexible adhesive film 44, exposing the adhesive bottom surface of the flexible adhesive film 44. The flexible adhesive film 44 adheres to the skin of the patient. When the procedure is performed, incisions may be made directly through the flexible adhesive film 44.


As illustrated, flexible adhesive film 44 is a full panel film that covers the entirety of fenestration 42. It is contemplated that a “fenestrated incise” structure (not shown) alternatively may be employed, wherein there is adhesive disposed around the perimeter of the fenestration. This leaves an opening in a center portion of the flexible adhesive film through which the patient's skin is exposed to permit incisions to be made directly though the exposed skin.


With further reference to FIG. 2, the fenestration 42 may be substantially surrounded by a fluid collection pouch 45. The fluid collection pouch 45 is made of a plastic material impervious to fluid. The fluid collection pouch 45 surrounds the fenestration 42 in a sealing fashion such that any fluids released from the surgical site during the procedure will run off the sheet into fluid collection pouch 45. This prevents fluids from running off the main sheet 11 and onto the floor or other areas where fluids are not desired. The fluid collection pouch 45 may include one or more suction ports 46 for connection to suction equipment for aspirating the fluids from the fluid collection pouch.


The fluid collection pouch 45 includes an opening 47 through which the surgeon may access fenestration 42. The edges of the opening 48 may be bound by a formable material 50, such as a malleable wire encased in plastic. The formable material 50 allows the surgeon to shape the opening of fluid collection pouch 45 to allow for easier access to fenestration 42 or to reconfigure the shape of fluid collection pouch 45 in a manner that is most effective for the particular procedure.


The main sheet 11 includes one or more line anchors 51 for securing wires or lines to the surgical drape 10. The line anchors 51 consist of two plies of hook and loop material that may be separated at one end, but which are attached at another end. When the plies of the hook and loop material are separated, a line may be inserted between the two plies and when the plies are joined again, the hook and loop material captures the line between the two plies of material.


The main sheet 11 also includes an absorbent pad 52, which, as shown, is configured as a separate pad disposed on the main sheet 11. Absorbent pad 52 is located near fenestration 42 and is made up of a material suitable for absorbing fluids generated during the surgical procedure. The absorbent pad 52 provides another measure of fluid retention in the instance where fluids are not collected by the fluid collection pouch 45.


As supplied, the surgical drape 10 is initially provided in a sterile folded state wrapped in a sterile fabric wrapper (not shown) and an outer package (also not shown), as is conventional. The sterile fabric wrapper surrounds the surgical drape 10 to protect the surgical drape 10 and maintain its sterile state. The surgical drape 10 wrapped in the sterile fabric wrapper is enclosed in a plastic pouch. The plastic pouch further protects the surgical drape 10 and maintains its sterile condition.


Referring to FIGS. 3 and 4, a bottom edge 27 of a substantially opaque screen 28 is attached to the patient-facing side of the transverse portion 16 sufficiently to preclude the patient from viewing the surgical field beneath the screen. Preferably the screen is attached below the point at which the bottom edge 25 of the substantially transparent sheet 24 is attached to the top edge 26 of the transverse portion 16. The substantially opaque screen 28 may be made of any suitable material, such as SMS non-woven fabric. A top edge 30 of the substantially opaque screen 28 is attached proximate its outer edges to the patient-facing side of substantially opaque screen 28 proximal a top edge 31 of the substantially transparent sheet 28. The attachment is made via first and second adhesive tape strips 32 and 34 discussed in more detail below.


Referring to FIG. 6, the top edge 30 of the substantially opaque screen 28 is attached to the patent-facing side of the transparent sheet 24 via the first and second adhesive tape strips 32 and 34. First and second adhesive tape strips 32 and 34 include first regions, 35, 35′ respectively, attached to the patient-facing side of the substantially transparent sheet 24. The strips include a second region 36, 36′ respectively attached along the top edge 30 of the substantially opaque screen 28. The first and second regions of each adhesive tape strip are connected to one another along a demarcated line of weakness, such as strip scoreline 37, 37′ that partially scores the first and second adhesive tape strips 32 and 34. The strip scorelines 37, 37′ is generally formed by severing the first and second adhesive tape strips 32 and 34 along their lengths partially through their thickness such that a separated area is formed above the bridging area between the first region and the second region of each strip. In this embodiment, the strip scorelines 37, 37′ are generally centrally positioned along the width of the first and second adhesive tape strips 32 and 34.


Thus, based at least in part on the relatively small thickness of the bridging area, the first region 35, 35′ can be separated from the second region 36, 36′ via manual tearing. Referring to FIG. 7, to detach the substantially transparent sheet 24 from the substantially opaque screen 28 a user may manually separate the first and second regions 35 and 36 of first and second adhesive tape strips 32 and 34. When the first and second regions 35 and 36 are severed along scoreline 37, the first region 35 remains attached to the patient-facing side of substantially transparent sheet 24. The second region 36 remains attached to the patient-facing side of substantially opaque screen 28. In this manner, the top edge 30 of the substantially opaque screen 28 is separated from the substantially transparent sheet 24. In this manner, the substantially opaque screen 28 may be detached and lowered to permit the patient to view the surgical area, as illustrated in FIG. 5.


Referring again to FIGS. 6 and 7, a first refastening strip 38 and a second refastening strip 40 are connected along the top edge 30 of the substantially opaque screen 28 on a side of the substantially opaque screen 28 proximal the first and second adhesive tape strips 32 and 34. First and second refastening strips 38 and 40 have two sides, both of which are covered by an adhesive. One side of each of the first and second refastening strips 38 and 40 is adhered to the substantially opaque screen 28. The other side of each of the refastening strips 38 and 40 is covered by a removable backing 41. The removable backing 41 may be removed to expose the adhesive material. Once the removable backing 41 is removed and the adhesive is exposed, the first and second refastening strips 38 and 40 may be used to re-adhere the substantially opaque screen 28 to the substantially transparent sheet 24 by pressing the exposed adhesive on refastening strips 38 and 40 to the patient-facing side of the substantially transparent sheet 24. Via these strips, after the patient views the surgical area, the substantially opaque screen 28 may be reattached to the substantially transparent sheet 24, as shown in FIG. 8.


As illustrated, the strips are disposed at the top of the screen, but other configurations are possible. For instance, the strips may be disposed at a different location on the screen, or may be provided on the substantially transparent sheet. Similarly, the sheet and screen are shown as being substantially rectilinear in configuration, but other shapes are possible, as is also possible for the main sheet. As an alternative to the adhesive strip, or in addition thereto, other implementations may be provided for refastening the substantially transparent sheet to the screen, these including, for instance, hook-and-loop material, ties, buttons, or other suitable fasteners. Such fasteners can be positioned in any manner suitable to effectuate refastening.


In using the surgical drape 10, the patient is first laid on a surgical table. Once the patient is in position on the surgical table, the surgical drape 10 is removed from the plastic pouch. At this point, the surgical drape 10 is enclosed within the sterile wrapper. A member of the surgical team may remove the wrapped surgical drape 10 from the container, and, by using methods known in the field, may unwrap the surgical drape 10 and present it to a member of the surgical team that has performed personal decontamination, such that the sterile state of the surgical drape 10 may be maintained during setup of the surgical procedure. After the surgical drape 10 is removed from the sterile wrapper, it is unfolded, and as it is unfolded it is lain over the patient. As it is unfolded and lain over the patient, when the portion of fenestration 42 is positioned over the surgical site of the patient, the removable adhesive backing is removed from the incise film 44, and the incise film 44 is adhered to the patient's skin and the site of the surgical area. The outer portions of substantially transparent sheet 24 are attached using spring clamps or other attaching means to N poles, or other standards used in operating rooms for positioning surgical drapes. The substantially transparent sheet 24 attached to the poles separates the patient's head from the sterile field. At this point in the procedure, the substantially opaque screen 28 remains attached to substantially transparent sheet 24 to occlude the view of the patient through the substantially transparent sheet 24, as seen in FIG. 4.


The surgical procedure may then proceed, and at a time at which the surgeon wishes to allow the patient to view an area around the surgical site, the substantially opaque screen 28 may be partially detached from substantially transparent sheet 24 to allow the patient to view the surgical area, as illustrated in FIG. 5. In the case of a C-section, this allows the new mother to view the newborn baby immediately after the baby is removed in the C-section procedure. After the mother has had an opportunity to view the baby, a member of the surgical team may reattach the substantially opaque screen 28 to the substantially transparent sheet 24 using the first and second refastening strips 38 and 40. The remainder of the surgical procedure may then be performed with the patient's vision in direction towards the surgical scene occluded.


It is thus seen that a drape that allows the surgeon to selectively permit the patient to view the area near the surgical field is provided. In a C-section procedure, the patient may or may not be able to view the actual surgical field, so long as she has a view through the substantially transparent sheet towards the surgeon-facing side of the drape. Notably, because the substantially opaque screen 28 remains outside of the sterile field, the risk of contamination is reduced even where the screen is removed and re-attached. The surgical drape 10 is particularly suitable for C-section procedures, but it is contemplated that the surgical drape 10 will find other surgical uses.


Uses of singular terms such as “a,” “an,” are intended to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. The terms “comprising,” “having,” “including,” and “containing” are to be construed as open-ended terms. Any description of certain embodiments as “preferred” embodiments, and other recitation of embodiments, features, or ranges as being preferred, or suggestion that such are preferred, is not deemed to be limiting. The invention is deemed to encompass embodiments that are presently deemed to be less preferred and that may be described herein as such. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein, is intended to illuminate the invention and does not pose a limitation on the scope of the invention. Any statement herein as to the nature or benefits of the invention or of the preferred embodiments is not intended to be limiting. This invention includes all modifications and equivalents of the subject matter recited herein as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context. The description herein of any reference or patent, even if identified as “prior,” is not intended to constitute a concession that such reference or patent is available as prior art against the present invention. No unclaimed language should be deemed to limit the invention in scope. Any statements or suggestions herein that certain features constitute a component of the claimed invention are not intended to be limiting unless reflected in the appended claims. Neither the marking of the patent number on any product nor the identification of the patent number in connection with any service should be deemed a representation that all embodiments described herein are incorporated into such product or service.

Claims
  • 1. A surgical drape comprising: a mainsheet having a mainsheet transverse width at a head region for placement proximal a head of a patient during a surgical procedure, the mainsheet having a fenestration therein permitting access to a surgical region for performance of the surgical procedure when the drape covers the patient during the surgical procedure, and having a surgeon-facing side and a patient facing side;a substantially transparent sheet having a surgeon-facing side and a patient-facing side, the substantially transparent sheet having a transverse width substantially equal to the mainsheet transverse width and connected to the mainsheet at a connecting location, said connecting location being adjacent said head region and providing the patient with visual access therethrough; anda substantially rectilinear, substantially opaque screen attached to the patient-facing side of the substantially transparent sheet and effective to occlude the patient's visual access through the substantially transparent sheet at the substantially opaque screen, said substantially opaque screen covering a portion of the substantially transparent sheet, the portion of the substantially tranparent sheet being less than a total surface area of the substantially transparent sheet, the substantially opaque screen attached below the connecting location, said substantially opaque screen being at least partially removable from said substantially transparent sheet to thereby permit the patient's visual access through the substantially transparent sheet, the substantially opaque screen having top and bottom boundaries, the substantially opaque screen being removably attached to the patient-facing side of the substantially transparent sheet proximal the top boundary of the substantially opaque screen,further comprising a fluid collection pouch at least partially surrounding said fenestration.
  • 2. The surgical drape of claim 1, the head region defining a top edge of the mainsheet.
  • 3. The surgical drape of claim 1, the substantially opaque screen being reconnectable to the patient-facing side of the substantially transparent sheet after the substantially opaque screen has been at least partially removed from said substantially transparent sheet wherein upon reconnection the substantially opaque screen is again effective to occlude the patient's visual access through the substantially transparent sheet.
  • 4. The surgical drape of claim 3, the drape being provided with an adhesive strip, the adhesive strip being covered with a removable covering material, the adhesive strip permitting reconnection of the substantially opaque screen to the patient-facing side of the substantially transparent sheet upon removal of the removable covering material.
  • 5. The surgical drape of claim 1, the drape comprising a strip of material connecting the substantially transparent sheet to the substantially opaque screen, the strip of material having a demarcated line of weakness connecting first and second regions of the strip of material, the first region of the strip of material connected to the substantially transparent sheet and the second region of the strip of material connected to the substantially opaque screen.
  • 6. A method, comprising: applying the surgical drape of claim 1 to a patient;at least partially disconnecting a substantially opaque screen portion of the surgical drape to allow the patient visual access to an area proximal a surgical region through the substantially transparent sheet of the surgical drape; andreconnecting the at least partially disconnected substantially opaque screen portion of the surgical drape to the patient-facing side of the substantially transparent sheet to occlude the patient's visual access to an area proximal a surgical region.
  • 7. The method of claim 6, where the partially disconnected substantially opaque screen portion is reconnected to the patient-facing side of the substantially transparent sheet by an adhesive strip.
  • 8. The method of claim 6, where the substantially opaque screen is disconnected from the substantially transparent sheet by severing a strip of material connecting the substantially transparent sheet to the substantially opaque screen along a demarcated line of weakness connecting first and second regions of the strip of material, the first region of the strip of material connected to the substantially transparent sheet and the second region of the strip of material connected to the substantially opaque screen.
  • 9. The surgical drape of claim 4, the drape being provided with at least one adhesive tape strip, the tape strip having a first region and a second region connected to one another along a demarcated line of weakness.
  • 10. A surgical drape comprising: a mainsheet having a fenestration therein permitting access to a surgical region for performance of a surgical procedure when the drape covers a patient during the surgical procedure, the mainsheet having a head region for placement proximal the head of the patient during the surgical procedure and having a surgeon-facing side and a patient-facing side;a substantially transparent sheet having a surgeon-facing side and a patient-facing side and joined to the mainsheet at said head region for providing the patient with visual access therethrough; anda substantially opaque screen attached to the patient-facing side of the substantially transparent sheet and effective to occlude the patient's visual access through the substantially transparent sheet, said substantially opaque screen being at least partially removable from said substantially transparent sheet to thereby permit the patient's visual access through the substantially transparent sheet, wherein the substantially transparent sheet has a first total surface area and the substantially opaque screen has a second total surface area that is less than the first total surface area of the substantially transparent sheet.
  • 11. The surgical drape of claim 10 wherein the mainsheet has a mainsheet transverse width at a terminal edge adjacent the head region, and wherein the substantially transparent sheet has a transverse width substantially equal to the mainsheet transverse width.
  • 12. The surgical drape of claim 10 wherein the substantially opaque screen has a screen transverse width that is less than a transverse width of the substantially transparent sheet.
  • 13. The surgical drape of claim 10 wherein the substantially opaque screen has a screen height that is less than a height of the substantially transparent sheet.
  • 14. A surgical drape comprising: a mainsheet having a mainsheet transverse width at a head region for placement proximal a head of a patient during a surgical procedure, the mainsheet having a fenestration therein permitting access to a surgical region for performance of the surgical procedure when the drape covers the patient during the surgical procedure, and having a surgeon-facing side and a patient-facing side;a substantially transparent sheet having a surgeon-facing side and a patient-facing side and having a transverse width substantially equal to the mainsheet transverse width, the substantially transparent sheet connected to the mainsheet at said head region for providing the patient with visual access therethrough; anda substantially opaque screen attached to the patient-facing side of the substantially transparent sheet and effective to occlude the patient's visual access through the substantially transparent sheet, said substantially opaque screen being at least partially removable from said substantially transparent sheet to thereby permit the patient's visual access through the substantially transparent sheet, wherein the substantially transparent sheet has a first total surface area and the substantially opaque screen has a second total surface area that is less than the first total surface area of the substantially transparent sheet.
  • 15. The surgical drape of claim 14 wherein the substantially opaque screen has a screen transverse width that is less than a transverse width of the substantially transparent sheet.
  • 16. The surgical drape of claim 14 wherein the substantially opaque screen has a screen height that is less than a height of the substantially transparent sheet.
US Referenced Citations (127)
Number Name Date Kind
3667458 Krebs Jun 1972 A
3698395 Hasson Oct 1972 A
3707964 Patience Jan 1973 A
3721242 Krusko Mar 1973 A
3750664 Collins Aug 1973 A
3763857 Schrading Oct 1973 A
3791381 Krzewinski Feb 1974 A
3799161 Collins Mar 1974 A
3826253 Larsh Jul 1974 A
4089331 Hartigan May 1978 A
4169472 Morris Oct 1979 A
4192312 Wilson Mar 1980 A
4205668 Criddle Jun 1980 A
D256161 Oliver Jul 1980 S
4384573 Elliott May 1983 A
4471769 Lockhart Sep 1984 A
4489720 Morris Dec 1984 A
4559937 Vinson Dec 1985 A
4586498 Morris May 1986 A
4616642 Martin Oct 1986 A
4798201 Rawlings Jan 1989 A
4869271 Idris Sep 1989 A
4890628 Jackson Jan 1990 A
4899762 Muller Feb 1990 A
4944737 Bloom Jul 1990 A
5042507 Dowdy Aug 1991 A
5060662 Farnswoth, III Oct 1991 A
5195893 Casale Mar 1993 A
5197493 Grier-Idris Mar 1993 A
5209243 Glassman May 1993 A
5345946 Butterworth Sep 1994 A
5380278 Mombrinie Jan 1995 A
5464024 Mills Nov 1995 A
D373921 Palomo Sep 1996 S
5778889 Jascomb Jul 1998 A
5778890 Lofgren Jul 1998 A
5800483 Vought Sep 1998 A
5803086 Scholz Sep 1998 A
5860420 Wiedner Jan 1999 A
5875780 Rodriguez Mar 1999 A
D408533 Niedospial, Jr. Apr 1999 S
5985395 Comstock Nov 1999 A
5991666 Vought Nov 1999 A
6007564 Haverstock Dec 1999 A
6019102 Becker Feb 2000 A
6032670 Miller Mar 2000 A
6199553 Hafer Mar 2001 B1
6213124 Butterworth Apr 2001 B1
6314958 Harroll Nov 2001 B1
6345621 Chandler Feb 2002 B1
D467345 Gingles Dec 2002 S
6497233 DeAngelis Dec 2002 B1
6612310 Sklar Sep 2003 B2
6694981 Gingles Feb 2004 B2
6725864 Ewonce Apr 2004 B2
6835256 Menzies Dec 2004 B2
6843252 Harrison Jan 2005 B2
6923186 Gavette Aug 2005 B2
6966320 Baynes Nov 2005 B1
7044132 Masini May 2006 B2
7059371 Renn Jun 2006 B2
7086404 Dusenbery Aug 2006 B2
D539904 Inoue Apr 2007 S
D541414 Wallace Apr 2007 S
7588034 Mathis Sep 2009 B2
D615646 Russell May 2010 S
7752768 Young Jul 2010 B2
7853311 Webb Dec 2010 B1
D637296 Matthews May 2011 S
8011371 Rotolo Sep 2011 B2
8079365 Block Dec 2011 B2
D653330 Ecabert Jan 2012 S
D653331 Ecabert Jan 2012 S
D653333 Ecabert Jan 2012 S
D653751 Ecabert Feb 2012 S
D653752 Pittet Feb 2012 S
D653753 Ecabert Feb 2012 S
8459265 Young Jun 2013 B2
D693603 Esquivel Nov 2013 S
8721629 Hardman May 2014 B2
8783262 Carrez Jul 2014 B2
8967150 Carrez Mar 2015 B2
D739012 Hanuka Sep 2015 S
9278166 Czajka, Jr. Mar 2016 B2
D796685 Ohizep Sep 2017 S
D838375 Cashin Jan 2019 S
D839440 Cashin Jan 2019 S
10188474 Jarrelle Jan 2019 B2
D851772 Haines Jun 2019 S
20010023697 Hinley Sep 2001 A1
20020174870 Ewonce Nov 2002 A1
20030051362 Buckman Mar 2003 A1
20030159966 McMichael Aug 2003 A1
20030187458 Carlson Oct 2003 A1
20030205233 Aboul-Hosn et al. Nov 2003 A1
20040103903 Falahee Jun 2004 A1
20040118049 Chen Jun 2004 A1
20040118409 Griesbach Jun 2004 A1
20050234322 Lober Oct 2005 A1
20060169290 Harris Aug 2006 A1
20060201521 Masini Sep 2006 A1
20060207609 Gil Sep 2006 A1
20060219249 Czajka Oct 2006 A1
20080006279 Bodenham Jan 2008 A1
20090158487 Paulsen Jun 2009 A1
20090277460 Carrez Nov 2009 A1
20100192960 Rotolo Aug 2010 A1
20100263678 Baumann Oct 2010 A1
20110015557 Aali Jan 2011 A1
20110030702 Czajka, Jr. Feb 2011 A1
20110041995 Adams Feb 2011 A1
20110126845 Hoffmann Jun 2011 A1
20110214679 Chua Sep 2011 A1
20110247634 Young Oct 2011 A1
20120017921 Esquivel Jan 2012 A1
20120222686 Lockwood Sep 2012 A1
20120222687 Czajka Sep 2012 A1
20120298115 Haines Nov 2012 A1
20130284187 Esquivel Oct 2013 A1
20130304080 Landry Nov 2013 A1
20130312770 Young Nov 2013 A1
20140012119 Geaghan Jan 2014 A1
20140261457 Lother Sep 2014 A1
20150135398 Czajka May 2015 A1
20150359596 Jarrelle Dec 2015 A1
20160135915 Czajka, Jr. May 2016 A1
20170258543 Chua Sep 2017 A1
Foreign Referenced Citations (14)
Number Date Country
201602900 Oct 2010 CN
201602902 Oct 2010 CN
101496742 Mar 2011 CN
102470019 May 2012 CN
2151211 Feb 2010 EP
445412 Oct 1974 SU
9510986 Apr 1995 WO
2006094062 Sep 2006 WO
2011088326 Jul 2011 WO
2012078620 Jun 2012 WO
2012161869 Nov 2012 WO
2013036387 Mar 2013 WO
2014083573 Jun 2014 WO
2015191953 Dec 2015 WO
Non-Patent Literature Citations (20)
Entry
Australian Patent Application No. 2012223335; Patent Examination Report No. 1; dated Aug. 14, 2015; 4 pages.
Canadian Patent Application No. 2,832,104; Office Action dated Aug. 12, 2015; 5 pages.
Extended European Search Report from European Application No. 12751757.1 dated Aug. 12, 2014.
International Search Report and Written Opinion; PCT Patent Application No. PCT/US2014/023215; dated Jul. 24, 2014.
Notification of the First Office Action dated Mar. 20, 2015 from Chinese Patent Application No. 2012800215110.
PCT, Notification Concerning Transmittal of International Preliminary Report on Patentability, in International Application No. PCT/US2012/27284, dated Sep. 12, 2013.
PCT, Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration, in International Application No. PCT/US12/27284, dated Jun. 29, 2012.
Chinese Patent Application No. 2012800215110; Office Action dated Nov. 4, 2015 with English translation.
Chinese Patent Application No. 2012800215110; Office Action dated Mar. 20, 2015 with English translation.
Australian Patent Application No. 2012223335; Patent Examination Report No. 2; dated Aug. 15, 2016; 6 pages.
Article 94(3) EPC from European Patent Application No. 12751757.1 dated Jan. 5, 2017; 7 pages.
International Search Report and Written Opinion from PCT/US2017/022278 dated Jun. 19, 2017; 11 pages.
International Search Report and Written Opinion from PCT/US2017/022450 dated Jun. 7, 2017; 12 pages.
Extended European Search Report from European Patent Application No. 17173255.5 dated Aug. 18, 2017; 10 pages.
European Extended Search Report for European Application No. 18200143 dated Mar. 29, 2019.
Medline Cesarean Section Surgical Drape with Pouch and Fenestration. No date specified. https://www.medline.com/product/Cesarean-Section-Surgical-Drape-with-Pouch-and-Fenestration/Z05-PF07160 (Year: 0).
European Supplementary Search Report for European Application No. 17767321, dated Oct. 18, 2019.
Australian Patent Application No. 2019200113; Patent Examination Report No. 1; dated May 10, 2019; 6 pages.
Chinese Office Action from corresponding Chinese Patent Application No. 201780017592.X dated Jul. 8, 2020 with English Translation; 22 pages.
Chinese Office Action with English translation from corresponding Chinese Patent Application No. 201780017592.X dated Jan. 27, 2021; 25 pages.
Related Publications (1)
Number Date Country
20170258543 A1 Sep 2017 US